CORZQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CORZQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Core Scientific's Total Liabilities for the quarter that ended in Mar. 2024 was $1,132.5 Mil. Core Scientific's Total Assets for the quarter that ended in Mar. 2024 was $814.0 Mil. Therefore, Core Scientific's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 was 1.39.
The historical data trend for Core Scientific's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Scientific Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Liabilities-to-Assets | 0.34 | 0.60 | 0.45 | 1.51 | 1.84 |
Core Scientific Quarterly Data | ||||||||||||||||
Dec19 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Liabilities-to-Assets | Get a 7-Day Free Trial | 1.54 | 1.52 | 1.59 | 1.84 | 1.39 |
For the Software - Infrastructure subindustry, Core Scientific's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Software industry and Technology sector, Core Scientific's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Core Scientific's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Core Scientific's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
Liabilities-to-Assets (A: Dec. 2023 ) | = | Total Liabilities | / | Total Assets |
= | 1309.097 | / | 712.156 | |
= | 1.84 |
Core Scientific's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 is calculated as
Liabilities-to-Assets (Q: Mar. 2024 ) | = | Total Liabilities | / | Total Assets |
= | 1132.477 | / | 813.968 | |
= | 1.39 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Scientific (OTCPK:CORZQ) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Thank you for viewing the detailed overview of Core Scientific's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Adam Taylor Sullivan | officer: President | C/O CORE SCIENTIFIC, INC., 2407 S. CONGRESS AVENUE, AUSTIN TX 78704 |
Darin Feinstein | director, 10 percent owner, officer: Chief Vision Officer | 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004 |
Sterling Denise Marie Brucia | officer: Chief Financial Officer | C/O CORE SCIENTIFIC, INC., 201 BARTON SPRINGS ROAD, AUSTIN TX 78704 |
Matt Minnis | director | 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004 |
Brian Neville | officer: Chief Accounting Officer | C/O CORE SCIENTIFIC, INC., 2800 NORTHROP WAY, BELLEVUE WA 98004 |
Todd M Duchene | officer: EVP, GC and Secretary | 847 GIBRALTAR DR., MILPITAS CA 95035 |
Michael Trzupek | officer: Chief Financial Officer | 2800 NORTHUP WAY, SUITE 220, BELLEVUE WA 98004 |
Stacie Olivares | director | 2525 E. CAMELBACK RD., STE 850, PHOENIX AZ 85016 |
Jarvis V. Hollingsworth | director | 100 WEST HOUSTON STREET, SAN ANTONIO TX 78205 |
Michael J Levitt | director, officer: Chief Executive Officer | KAYNE ANDERSON CAPITAL ADVISORS, L.P., 1800 AVENUE OF THE STARS, 3RD FLOOR, LOS ANGELES CA 90067 |
Dr Kneeland Youngblood | director | C/O GAP, INC., 2 FOLSOM ST., SAN FRANCISCO CA 94105 |
John P Mcgarrity | officer: General Counsel and Secretary | 321 N. CLARK STREET, CHICAGO IL 60054 |
Sullivan Colleen | director | 420 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA 92037 |
Theodore J Brombach | 10 percent owner | 321 N. CLARK STREET, CHICAGO IL 60054 |
Patrick C Eilers | director, 10 percent owner, officer: Chief Executive Officer | THREE FIRST NATIONAL PLAZA STE 3800, CHICAGO IL 60602 |
From GuruFocus
By PRNewswire PRNewswire • 12-22-2022
By Value_Insider Value_Insider • 12-19-2022
By Tiesvg Tiesvg • 12-24-2022
By PRNewswire PRNewswire • 12-26-2022
By PRNewswire PRNewswire • 12-24-2022
By PRNewswire PRNewswire • 12-20-2022
By Value_Insider Value_Insider • 12-17-2022
By Stock market mentor Stock market mentor • 01-02-2023
By Tiesvg Tiesvg • 12-27-2022
By PRNewswire PRNewswire • 12-27-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.